Neopterin is Associated with Disease Severity and Outcome in Patients with Non-Ischaemic Heart Failure
Open Access
- 17 December 2019
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (12) , 2230
Abstract
Inflammation and immune activation play an important role in the pathogenesis of cardiac remodelling in patients with heart failure. The aim of this study was to assess whether biomarkers of inflammation and immune activation are linked to disease severity and the prognosis of heart failure patients. In 149 patients (65.8% men, median age 49.7 years) with heart failure from nonischaemic cardiomyopathy, the biomarkers neopterin and C-reactive protein were tested at the time of diagnosis. Patients were followed-up for a median of 58 months. During follow-up, nineteen patients died, five had a heart transplantation, two needed a ventricular assistance device, and twenty-one patients had to be hospitalised because of heart failure decompensation. Neopterin concentrations correlated with N-terminal prohormone of brain natriuretic peptide (NT-proBNP) concentrations (rs = 0.399, p < 0.001) and rose with higher New York Heart Association (NYHA) class (I: 5.60 nmol/L, II: 6.90 nmol/L, III/IV: 7.80 nmol/L, p = 0.033). Higher neopterin levels were predictive for an adverse outcome (death or hospitalisation due to HF decompensation), independently of age and sex and of established predictors in heart failure such as NYHA class, NT-proBNP, estimated glomerular filtration rate (eGFR), and left ventricular ejection fraction (LV-EF) (HR 2.770; 95% CI 1.419–5.407; p = 0.003). Patients with a neopterin/eGFR ratio ≥ 0.133 (as a combined marker for immune activation and kidney function) had a more than eightfold increased risk of reaching an endpoint compared to patients with a neopterin/eGFR ratio ≤0.065 (HR 8.380; 95% CI 2.889–24.308; p < 0.001). Neopterin is associated with disease severity and is an independent predictor of prognosis in patients with heart failure.Keywords
This publication has 43 references indexed in Scilit:
- Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectorisAtherosclerosis, 2009
- Neopterin — Marker of coronary artery disease activity or extension in patients with chronic stable angina?International Journal of Cardiology, 2009
- Long-Term Prognostic Value of NeopterinCirculation, 2007
- Autonomic imbalance and immune activation in chronic heart failure — Pathophysiological linksCardiovascular Research, 2006
- Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectorisEuropean Heart Journal, 2005
- Stress-Activated Cytokines and The Heart: From Adaptation to MaladaptationAnnual Review of Physiology, 2003
- Sepsis and mechanisms of inflammatory response: is exercise a good model?British Journal of Sports Medicine, 2001
- Endotoxin and immune activation in chronic heart failure: a prospective cohort studyThe Lancet, 1999
- Increased concentrations of neopterin in carotid atherosclerosisAtherosclerosis, 1994
- Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.Journal of Experimental Medicine, 1983